Utility of noninvasive biomarker testing and MRI to predict a prostate cancer diagnosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Utility of noninvasive biomarker testing and MRI to predict a prostate cancer diagnosis ; day:24 ; month:9 ; year:2023 ; pages:1-8
International urology and nephrology ; (24.9.2023), 1-8
- Creator
-
Sultan, Mark I.
Huynh, Linda M.
Kamil, Sarah
Abdelaziz, Ahmad
Hammad, Muhammed A.
Gin, Greg E.
Lee, David I.
Youssef, Ramy F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11255-023-03786-9
- URN
-
urn:nbn:de:101:1-2023121213201331477945
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sultan, Mark I.
- Huynh, Linda M.
- Kamil, Sarah
- Abdelaziz, Ahmad
- Hammad, Muhammed A.
- Gin, Greg E.
- Lee, David I.
- Youssef, Ramy F.
- SpringerLink (Online service)
Other Objects (12)
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy
Utility of diffusion weighted imaging-based radiomics nomogram to predict pelvic lymph nodes metastasis in prostate cancer
Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder
The Utility of Molecular Imaging in Prostate Cancer
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
SNW1 is a prognostic biomarker in prostate cancer
Urinary BLACAT1 as a non-invasive biomarker for bladder cancer
Salivary uric acid as a noninvasive biomarker of metabolic syndrome
Glutamine as a Potential Noninvasive Biomarker for Human Embryo Selection
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy
Utility of diffusion weighted imaging-based radiomics nomogram to predict pelvic lymph nodes metastasis in prostate cancer
Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder
The Utility of Molecular Imaging in Prostate Cancer
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
SNW1 is a prognostic biomarker in prostate cancer
Urinary BLACAT1 as a non-invasive biomarker for bladder cancer
Salivary uric acid as a noninvasive biomarker of metabolic syndrome
Glutamine as a Potential Noninvasive Biomarker for Human Embryo Selection
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy
Utility of diffusion weighted imaging-based radiomics nomogram to predict pelvic lymph nodes metastasis in prostate cancer
Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder
The Utility of Molecular Imaging in Prostate Cancer
Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
Utility of Prostate-Specific Antigen Isoforms and Prostate Health Index in the Diagnosis of Metastatic Prostate Cancer
PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
SNW1 is a prognostic biomarker in prostate cancer
Urinary BLACAT1 as a non-invasive biomarker for bladder cancer
Salivary uric acid as a noninvasive biomarker of metabolic syndrome